Rising Health Issues Expected to Drive the Women's Health Market's Growth


Womens under the reproductive age which is around 50, in this range the health problems affecting women such as hormonal infertility, endometriosis, and polycystic ovary syndrome, are more likely to be connected to fertility. The World Bank estimates that, out of the 3.8 billion women globally, 1.9 billion were between the ages of 15 and 49 in 2020, making up 64.8% of all females. The above-mentioned elements all influence the market's expansion.

According to Data Bridge Market Research the Women’s Health Market accounted for USD 34.45 billion in 2021, and expected to reach USD 52.27 billion by 2029. The market is expected to grow with a CAGR of 5.35% in the forecast period of 2022 to 2029.

“Increased the Number of Unsafe Abortions Will Aid Growth”

The availability of contraception and gynaecological testing has declined, which has led to a rise in unsafe abortions and unintended pregnancies, especially in poor nations. The BMC reports a 10% decrease in the usage of long- and short-acting reversible contraceptives as well as a 10% decrease in the availability of crucial prenatal care services in low- and middle-income nations. During the pandemic, none of these variables helped to sustain market growth. Osteoporosis, osteoarthritis, endometriosis, and menstrual health issues are just a few of the diseases that are more common in women.

What restraints the growth of Women's Health Market?

“Scarcity of Reimbursements Are Expected to Hamper the Market's Growth”

One of the main issues preventing the growth of the women's Health market during the forecast period is a lack of standards and regulations, along with a lack of reimbursements, limited medical help in app selection, and resistance from traditional healthcare providers.

 Segmentation: Women's Health Market

The women’s health market is segmented on the basis of drugs, application. 

  • On the basis of drugs, the market is segmented into prolia, xgeva, evista, mirena, zometa, reclast or aclasta, minastrin 24 Fe, FORTEO, nuvaring, primarin, ACTONEL, ORTHO TRI-CY LO (28).
  • On the basis of application, the market is segmented into hormonal infertility, female infertility, postmenopausal osteoporosis, endometriosis, contraception, polycystic ovary syndrome (PCOS), menopause, other applications.

Regional Insights: North America is expected to dominate the Women's Health Market

North America is expected to dominate the market due to increased penetration of smartphones, rising utilization of connected devices and health apps for the management of chronic diseases and the presence of major companies in this region.

In addition, the Asia-Pacific region is likely to register highest growth rate during the forecast period of 2022 to 2029 owing to growing awareness about women’s health and wellbeing, growing geriatric population and various government initiatives for increasing health awareness.

To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-womens-health-market

Recent Developments in Women's Health Market

  • In 2022, Sun Pharma announced the arrival of Cequa, a dry eye medication, in Canada. It is the first treatment for dry eye illness to use nanomicellar (NCELL) technology. This method increases the cyclosporine's bioavailability and physiochemical stability to increase eye tissue penetration.

The Prominent Key Players Operating in the Women's Health Market Include:

  • Siemens (Germany)
  • Hologic, Inc. (U.S.)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Abbott (U.S.)
  • BD (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Thermo Fisher Scientific (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • NeuroLogica Corp. (U.S.)
  • Shimadzu Medical (India) pvt. Ltd. (Japan)
  • General Electric (U.S.)
  • Quest Diagnostics Incorporated (U.S.)
  • Sysmex India Pvt. Ltd. (Japan)
  • Hitachi, Ltd. (Japan)
  • Canon Inc. (Japan)
  • FUJIFILM Holdings Corporation (U.K.)

Above are the key players covered in the report, to know about more and exhaustive list of women’s health    market companies contact, https://www.databridgemarketresearch.com/contact

Research Methodology: Global Women's Health Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.